WILLOW BIOSCIENCES REPORTS 2024 FINANCIAL RESULTS AND UPDATE REGARDING SALE OF OPERATING SUBSIDIARY
Sunnyvale, California – March 24, 2025 – Willow Biosciences Inc.(“Willow” or the “Company”) (TSX: WLLW; OTCQB: CANSF), a biotechnology company focused on industrial manufacturing of ingredients is pleased to announce its financial and operating results for the three months and year ended December 31, 2024, and an update in respect of the disposition of Company’s operating […]
WILLOW ANNOUNCES SALE OF OPERATING SUBSIDIARY
Calgary, Alberta – March 14, 2025 – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQB: CANSF), a biotechnology company focused on industrial manufacturing of ingredients, announces that it has entered into a definitive agreement dated March 14, 2025 (the “Agreement“) with an privately-held, arms-length entity based in the United Kingdom (the “Purchaser“), pursuant to which […]
WILLOW ANNOUNCES INITIATION OF STRATEGIC REVIEW PROCESS
Sunnyvale, California – January 20, 2025 – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, announces that it has initiated a formal strategic review process to identify, assess and evaluate a broad range of potential strategic alternatives. Willow’s board […]
WILLOW ANNOUNCES CANCELLATION OF PREVIOUSLY ANNOUNCED NON-BROKERED OFFERING TO PURSUE LESS DILUTIVE ALTERNATIVES
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Sunnyvale, California – January 2, 2025 – Willow Biosciences Inc. (“Willow” or the “Company”) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, announces that it will not be proceeding with the non-brokered […]
WILLOW ANNOUNCES NON-BROKERED PRIVATE PLACEMENT OFFERINGTO RAISE UP TO $2.0 MILLION
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Sunnyvale, California – November 18, 2024 – Willow Biosciences Inc. (“Willow” or the “Company”) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, announces its intention to complete a non-brokered private placement offering […]
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Company reports record revenue of $1.7 million in Q3 Company announced a partnership in the high growth biopesticides sector that is expected to generate over $2 million in revenue in its first year Company closed a brokered financing for aggregate gross proceeds of $1.6 million Company signed a royalty agreement with Kalsec that includes milestone […]